Screener
LeMaitre Vascular LMAT Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.
The source filing: LeMaitre Vascular’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 7:01 AM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-073360
| Line item | Year ended December 31, 2025 | Year ended December 31, 2024 | Year ended December 31, 2023 |
|---|---|---|---|
| Provision (benefit) for deferred income taxes | 2,312 | (451) | 783 |
| Loss on divestitures | - | - | 485 |
| Provision for credit losses | 817 | 813 | 344 |
| Unrealized loss on equity investments | 535 | - | - |
| Fair value adjustments to contingent consideration obligations | - | 134 | (78) |
| Foreign currency transaction effect on income | (176) | 362 | (705) |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | (2,947) | (6,418) | (3,135) |
Item 16. Form 10-K Summary.
FAQ
- What is LeMaitre Vascular's net gains (losses) on investments?
- LeMaitre Vascular (LMAT) reported net gains (losses) on investments of -$133.75K in Q4 2025.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about LeMaitre Vascular's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude